Phase 2Enrolling by invitationHealthspan endpoint

Tirzepatide and Organ-specific Biological Aging

Tirzepatide and Organ-Specific Biological Aging: A Parallel-Design Feasibility Study Using Proteomic Organ Clocks in a Preventive Brain Health Cohort

Sponsor
Atria Research and Global Health Institute (ARGHI) (Academic or other)
Enrollment
22 planned
Conditions
Longevity; Preventive Medicine; Biological Ageing
Interventions
Tirzepatide
Ages
adults, older adults
Registry
NCT07906041

Full record on ClinicalTrials.gov

From the registry

The purpose of this study is to evaluate blood-based measures of organ-specific biological age, with a particular focus on the brain, and to investigate their relationship with established clinical indicators of health and their response to treatment with tirzepatide.

Primary outcomes

  • Change in Proteomic Brain Age Gap From Baseline to Month 6

History

  1. Study completion expected

  2. Primary completion expected

  3. Last registry update

  4. Registered

  5. Started